# Zebrafish as a Model for Cardiovascular Disease Using Nanotechnology and Emerging Optogenetic Tools

## TL;DR

This paper reviews how zebrafish are used with nanotechnology and optogenetics to study heart disease and improve drug testing.

## Contribution

The paper highlights novel applications of nanotechnology and optogenetics in zebrafish for cardiovascular disease modeling.

## Key findings

- Zebrafish offer transparency and genetic tools for real-time cardiovascular studies.
- Nanoparticles and optogenetics enable precise drug delivery and cardiac control.
- Optogenetic systems allow light-based manipulation of cardiac signaling pathways.

## Abstract

Recent advances in experimental model systems have improved our ability to study cardiovascular development, function, and disease with high spatial and temporal resolution. The zebrafish (Danio rerio) has emerged as a powerful vertebrate model for cardiovascular research due to its transparency, genetic tractability, and conserved cardiac physiology, similar to humans. These features allow real-time in vivo imaging, the functional assessment of cardiac performance, and the tracking of signaling pathways that are fundamental in cardiovascular development and disease. Recent advances in nanotechnology and optogenetics have introduced complementary tools for probing and manipulating cardiovascular systems with high spatial and temporal precision. Nanoparticle-based platforms enable the tunable delivery of drugs, nucleic acids, and imaging agents, while optogenetic systems allow the light-mediated control of gene expression, signaling pathways, and cardiac electrophysiology. In this review, we summarize recent progress in the application of nanoparticle-based technologies and the emerging optogenetic tools in zebrafish cardiovascular research, including the optical control of cardiac signaling and electrophysiology. We briefly discuss emerging complementary efforts toward nanoparticle and optogenetic approaches, how to overcome key technical limitations, such as light penetration and gene delivery, and how to facilitate the development of fully optical platforms for cardiovascular disease modeling and drug screening.